BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease
Saideh Fakharzadeh,1,2 Hassan Argani,1 Simin Dadashzadeh,3 Somayeh Kalanaky,2 Peyman Mohammadi Torbati,4 Mohammad Hassan Nazaran,2 Abbas Basiri5 1Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Department of Research and Development, Sodour Ahra...
Enregistré dans:
Auteurs principaux: | Fakharzadeh S, Argani H, Dadashzadeh S, Kalanaky S, Mohammadi Torbati P, Nazaran MH, Basiri A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6ca95d4cb0cc4c39978d2b738cb55c0c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
DIBc, a nanochelating-based nano metal-organic framework, shows anti-diabetic effects in high-fat diet and streptozotocin-induced diabetic rats
par: Fakharzadeh S, et autres
Publié: (2019) -
GFc7 as a Smart Growth Nanofactor for ex vivo Expansion and Cryoprotection of Humans’ Hematopoietic Stem Cells
par: Hafizi M, et autres
Publié: (2020) -
Metastatic and locally aggressive BCC: Current treatment options
par: Máire‐Caitlín Casey, et autres
Publié: (2021) -
Chronic Kidney Disease Related Anemia- A Narrative Review
par: Martina Hrvačić, et autres
Publié: (2021) -
Renal Expression of AQP1 in the High-fat Nutritional Obesity of Rat
par: Wang,Jinbao, et autres
Publié: (2019)